Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?

Abstract The precise mechanistic action of acetaminophen (ACT; paracetamol) remains debated. ACT’s analgesic and antipyretic actions are attributed to cyclooxygenase (COX) inhibition preventing prostaglandin (PG) synthesis. Two COX isoforms (COX1/2) share 60% sequence structure, yet their functions...

Full description

Bibliographic Details
Main Authors: Christopher J. Esh, Bryna C. R. Chrismas, Alexis R. Mauger, Lee Taylor
Format: Article
Language:English
Published: Wiley 2021-08-01
Series:Pharmacology Research & Perspectives
Subjects:
Online Access:https://doi.org/10.1002/prp2.835
_version_ 1818881217119911936
author Christopher J. Esh
Bryna C. R. Chrismas
Alexis R. Mauger
Lee Taylor
author_facet Christopher J. Esh
Bryna C. R. Chrismas
Alexis R. Mauger
Lee Taylor
author_sort Christopher J. Esh
collection DOAJ
description Abstract The precise mechanistic action of acetaminophen (ACT; paracetamol) remains debated. ACT’s analgesic and antipyretic actions are attributed to cyclooxygenase (COX) inhibition preventing prostaglandin (PG) synthesis. Two COX isoforms (COX1/2) share 60% sequence structure, yet their functions vary. COX variants have been sequenced among various mammalian species including humans. A COX1 splice variant (often termed COX3) is purported by some as the elusive target of ACT’s mechanism of action. Yet a physiologically functional COX3 isoform has not been sequenced in humans, refuting these claims. ACT may selectively inhibit COX2, with evidence of a 4.4‐fold greater COX2 inhibition than COX1. However, this is markedly lower than other available selective COX2 inhibitors (up to 433‐fold) and tempered by proof of potent COX1 inhibition within intact cells when peroxide tone is low. COX isoform inhibition by ACT may depend on subtle in vivo physiological variations specific to ACT. In vivo ACT efficacy is reliant on intact cells and low peroxide tone while the arachidonic acid concentration state can dictate the COX isoform preferred for PG synthesis. ACT is an effective antipyretic (COX2 preference for PG synthesis) and can reduce afebrile core temperature (likely COX1 preference for PG synthesis). Thus, we suggest with specificity to human in vivo physiology that ACT: (i) does not act on a third COX isoform; (ii) is not selective in its COX inhibition; and (iii) inhibition of COX isoforms are determined by subtle and nuanced physiological variations. Robust research designs are required in humans to objectively confirm these hypotheses.
first_indexed 2024-12-19T14:58:21Z
format Article
id doaj.art-3deb29cb797d4cf3addbc900938cb1ff
institution Directory Open Access Journal
issn 2052-1707
language English
last_indexed 2024-12-19T14:58:21Z
publishDate 2021-08-01
publisher Wiley
record_format Article
series Pharmacology Research & Perspectives
spelling doaj.art-3deb29cb797d4cf3addbc900938cb1ff2022-12-21T20:16:38ZengWileyPharmacology Research & Perspectives2052-17072021-08-0194n/an/a10.1002/prp2.835Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?Christopher J. Esh0Bryna C. R. Chrismas1Alexis R. Mauger2Lee Taylor3Aspetar—Qatar Orthopaedic and Sports Medicine HospitalResearch and Scientific SupportAspire Zone Doha QatarDepartment of Physical Education College of Education Qatar University Doha QatarEndurance Research Group School of Sport and Exercise Sciences University of Kent Chatham Maritime UKSchool of Sport, Exercise and Health Sciences Loughborough University Loughborough UKAbstract The precise mechanistic action of acetaminophen (ACT; paracetamol) remains debated. ACT’s analgesic and antipyretic actions are attributed to cyclooxygenase (COX) inhibition preventing prostaglandin (PG) synthesis. Two COX isoforms (COX1/2) share 60% sequence structure, yet their functions vary. COX variants have been sequenced among various mammalian species including humans. A COX1 splice variant (often termed COX3) is purported by some as the elusive target of ACT’s mechanism of action. Yet a physiologically functional COX3 isoform has not been sequenced in humans, refuting these claims. ACT may selectively inhibit COX2, with evidence of a 4.4‐fold greater COX2 inhibition than COX1. However, this is markedly lower than other available selective COX2 inhibitors (up to 433‐fold) and tempered by proof of potent COX1 inhibition within intact cells when peroxide tone is low. COX isoform inhibition by ACT may depend on subtle in vivo physiological variations specific to ACT. In vivo ACT efficacy is reliant on intact cells and low peroxide tone while the arachidonic acid concentration state can dictate the COX isoform preferred for PG synthesis. ACT is an effective antipyretic (COX2 preference for PG synthesis) and can reduce afebrile core temperature (likely COX1 preference for PG synthesis). Thus, we suggest with specificity to human in vivo physiology that ACT: (i) does not act on a third COX isoform; (ii) is not selective in its COX inhibition; and (iii) inhibition of COX isoforms are determined by subtle and nuanced physiological variations. Robust research designs are required in humans to objectively confirm these hypotheses.https://doi.org/10.1002/prp2.835acetaminophenarachidonic acidcyclooxygenasemechanism of action
spellingShingle Christopher J. Esh
Bryna C. R. Chrismas
Alexis R. Mauger
Lee Taylor
Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
Pharmacology Research & Perspectives
acetaminophen
arachidonic acid
cyclooxygenase
mechanism of action
title Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
title_full Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
title_fullStr Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
title_full_unstemmed Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
title_short Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
title_sort pharmacological hypotheses is acetaminophen selective in its cyclooxygenase inhibition
topic acetaminophen
arachidonic acid
cyclooxygenase
mechanism of action
url https://doi.org/10.1002/prp2.835
work_keys_str_mv AT christopherjesh pharmacologicalhypothesesisacetaminophenselectiveinitscyclooxygenaseinhibition
AT brynacrchrismas pharmacologicalhypothesesisacetaminophenselectiveinitscyclooxygenaseinhibition
AT alexisrmauger pharmacologicalhypothesesisacetaminophenselectiveinitscyclooxygenaseinhibition
AT leetaylor pharmacologicalhypothesesisacetaminophenselectiveinitscyclooxygenaseinhibition